You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Akorn Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for AKORN, and what generic and branded alternatives to AKORN drugs are available?

AKORN has twenty-six approved drugs.

There are two tentative approvals on AKORN drugs.

Drugs and US Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn NYSTATIN nystatin SUSPENSION;ORAL 064042-001 Feb 28, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075386-001 Jun 30, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn LEVOFLOXACIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 090268-001 Dec 20, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn NEMBUTAL pentobarbital sodium SUPPOSITORY;RECTAL 083247-001 Jan 25, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.